The rise of Sildenafil initially fueled a surge for the drug industry, however recent changes present a complicated picture for investors. Lower-cost alternatives are eroding revenue, and ongoing litigation add more https://barryccqs829733.ampblogs.com/sildenafil-and-big-pharma-a-volatile-bet-78081343